Ledyard National Bank’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
– Sell
-250
Closed -$36K – 747
2016
Q4
$36K Sell
250
-250
-50% -$33.5K 0.01% 342
2016
Q3
$63K Hold
500
– – 0.01% 294
2016
Q2
$66K Hold
500
– – 0.01% 277
2016
Q1
$69K Hold
500
– – 0.01% 292
2015
Q4
$70K Hold
500
– – 0.01% 281
2015
Q3
$70K Hold
500
– – 0.01% 269
2015
Q2
$82K Hold
500
– – 0.01% 251
2015
Q1
$77K Hold
500
– – 0.01% 246
2014
Q4
$63K Buy
500
+400
+400% +$49.4K 0.01% 269
2014
Q3
$12K Hold
100
– – ﹤0.01% 445
2014
Q2
$11K Buy
+100
New +$10.3K ﹤0.01% 470

Other funds holding ELV

Ledyard National Bank's ELV Position: Q1 2017 in Review

Ledyard National Bank sold out of Elevance Health (ELV) in Q1 2017, closing a stake of 250 shares — an estimated $36K sold.

Ledyard National Bank first reported a position in ELV in Q2 2014 and held it in 11 quarters. The position peaked at $82K in Q2 2015. 796 funds tracked by Wall St. Rank hold ELV as of Q1 2017.

  • Ledyard National Bank reported no remaining Elevance Health position as of Q1 2017 after selling out during the quarter.
  • Ledyard National Bank sold 250 Elevance Health shares in Q1 2017, an estimated $36K.
  • Ledyard National Bank first reported a position in Elevance Health in Q2 2014 and held it in 11 quarters.
  • Ledyard National Bank's Elevance Health position peaked at $82K in Q2 2015.
  • 796 funds tracked by Wall St. Rank held Elevance Health as of Q1 2017.

Based on Ledyard National Bank's 13F filing for Q1 2017, filed 19 Apr 2017.